Insiders BioMarin Pharmaceutical Inc.

Equities

BMRN

US09061G1013

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 12:48:23 14/05/2026 am IST			5-day change	1st Jan Change
53.52 ^USD	+1.22%		-2.13%	-10.09%

11/05	AI Bulls Face a Busy Week
11/05	Analyst recommendations: Biomarin Pharmaceuticals, Walt Disney, Apollo Global Management, Datadog, Roku…

Insiders

22/04	BioMarin Pharmaceutical Inc. Announces Retirement of Richard A. Meier as Chair of the Board	CI
27/02	Biomarin Pharmaceutical Insider Sold Shares Worth $1,599,103, According to a Recent SEC Filing	MT
13/01	BioMarin Pharmaceutical Names Arpit Dave Chief Digital and Information Officer	MT
13/01	BioMarin Pharmaceutical Inc. Appoints Arpit Davé as Executive Vice President and Chief Digital and Information Officer	CI
18/12	BioMarin Pharmaceutical Inc. Appoints Rashmi Ramchandani as Chief Accounting Officer, Effective January 19, 2026	CI
12/25/12	BioMarin Pharmaceutical Inc. Announces Resignation of Chief Accounting Officer ,Effective September 2, 2025	CI
01/25/01	Biomarin Pharmaceutical announces appointment of Ian T. Clark to board of directors	RE
01/25/01	BioMarin Pharmaceutical Inc. Announces Appointment of Ian T. Clark to Board of Directors, Effective August 1, 2025	CI
25/25/25	BioMarin Pharmaceutical Inc. Announces Appointment of Timothy P. Walbert to Board of Directors	CI
15/24/15	Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing	MT
21/24/21	BioMarin Pharmaceutical Inc. Announces Management Changes	CI
31/24/31	BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing	MT
14/24/14	Biomarin Pharmaceutical Insider Sold Shares Worth $3,255,200, According to a Recent SEC Filing	MT
07/24/07	Biomarin Pharmaceutical Insider Sold Shares Worth $414,550, According to a Recent SEC Filing	MT
16/24/16	Biomarin Pharmaceutical Insider Sold Shares Worth $3,645,000, According to a Recent SEC Filing	MT
02/24/02	Biomarin Pharmaceutical Insider Sold Shares Worth $2,173,341, According to a Recent SEC Filing	MT
08/24/08	Biomarin Pharmaceutical Insider Sold Shares Worth $348,280, According to a Recent SEC Filing	MT
08/24/08	BioMarin Pharmaceutical Appoints Cristin Hubbard as Chief Commercial Officer	MT
07/24/07	Biomarin Announces Board Changes, Effective May 20, 2024	CI
12/24/12	Biomarin Pharmaceutical Inc. Announces Resignation of Jeffrey Ajer as Executive Vice President and Chief Commercial Officer, Effective from July 1, 2024	CI
12/24/12	Biomarin Pharmaceutical Insider Sold Shares Worth $1,945,700, According to a Recent SEC Filing	MT
23/23/23	Biomarin Pharmaceutical Insider Sold Shares Worth $939,900, According to a Recent SEC Filing	MT
21/23/21	BioMarin Pharmaceutical Inc. Announces Board Appointments, Effective December 27, 2023	CI
15/23/15	Biomarin Pharmaceutical Insider Sold Shares Worth $1,311,709, According to a Recent SEC Filing	MT
07/23/07	Activist investor Elliott targets drugmaker BioMarin -sources	RE